Zai Lab Limited operates as a bio-pharmaceutical company. The Company researches and develops therapeutic technology for antibody-based oncology, autoimmune, and infectious diseases treatments. Zai Lab also manufactures drugs in the form of capsules, injections, and liquids. Zai Lab serves patients worldwide.

S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers

Annual Report (Form 10-K | Period ending 2023-12-31)

Zai Lab Ltd (ZLAB US)

S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers

Annual Report (Form 10-K | Period ending 2023-12-31)

Current Report (Form 8-K | Period ending 2024-02-27)

Current Report (Form 8-K | Period ending 2024-02-05)

Statement of changes in beneficial ownership of securities - general instructions (PDF)

S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers

Annual Report (Form 10-K | Period ending 2023-12-31)

Current Report (Form 8-K | Period ending 2024-02-27)

Current Report (Form 8-K | Period ending 2024-02-05)

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Statement of changes in beneficial ownership of securities - general instructions (PDF)